Gene: PSCA
Official Full Name: prostate stem cell antigenprovided by HGNC
Gene Summary: This gene encodes a glycosylphosphatidylinositol-anchored cell membrane glycoprotein. In addition to being highly expressed in the prostate it is also expressed in the bladder, placenta, colon, kidney, and stomach. This gene is up-regulated in a large proportion of prostate cancers and is also detected in cancers of the bladder and pancreas. This gene includes a polymorphism that results in an upstream start codon in some individuals; this polymorphism is thought to be associated with a risk for certain gastric and bladder cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09978 | PSCA Knockout cell line (HeLa) | Human | PSCA | 1:3~1:6 | Negative | Online Inquiry |
KO09979 | PSCA Knockout cell line (A549) | Human | PSCA | 1:3~1:4 | Negative | Online Inquiry |
PSCA Gene Knockout Cell Lines are specifically engineered cellular models in which the prostate stem cell antigen (PSCA) gene has been disrupted using advanced gene-editing technologies, such as CRISPR-Cas9. These knockout cell lines serve as vital tools in dissecting the role of PSCA in various biological processes, particularly in cancer biology, as PSCA is known to be overexpressed in several malignancies, including prostate and bladder cancers.
The primary function of PSCA Gene Knockout Cell Lines is to allow researchers to study the cellular consequences of PSCA absence, providing insights into cancer cell proliferation, apoptosis, differentiation, and tumor microenvironment interactions. By utilizing these cell lines, scientists can evaluate gene function, analyze signaling pathways, and test therapeutic interventions in a controlled environment. The knockout model effectively mimics the loss-of-function mutations found in many tumors, facilitating the exploration of potential cancer treatments and biomarkers.
The scientific importance of these cell lines lies in their ability to contribute to the understanding of PSCA as a biomarker for cancer diagnosis and prognosis and as a target for therapeutic strategies. They provide a platform for preclinical studies to evaluate the efficacy of PSCA-targeted therapies, making them invaluable in both research laboratories and clinical settings.
Compared to traditional cell line models, which may still express the PSCA gene at varying levels, our Gene Knockout Cell Lines offer a definitive and reproducible system for studying the effects of complete PSCA absence. This targeted approach not only streamlines experimental design but also enhances the accuracy and relevance of research findings.
Researchers and clinicians can greatly benefit from the high fidelity and specificity of these cell lines, bolstering their quests for effective cancer therapies and better understanding disease mechanisms. The ability to create and manipulate these established cell lines provides an important advantage in developing novel treatment strategies.
As a company committed to advancing biological research, we specialize in providing high-quality gene knockout models that adhere to strict standards of reproducibility and characterization. Our expertise ensures that researchers have access to reliable tools that can propel their studies forward, contributing to the ongoing fight against cancer and advancing the field of precision medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.